IL10 and inflammatory bowel disease: Considering that IBD is a relapsing inflammatory disorder, we further evaluated whether intraperitoneally delivered MSC-induced IL-10 secretion of peritoneal B cells could prevent colitis recurrence via a relapsing mouse model of colitis (Figure 3A), established by four administrations of TNBS as previously described (39).